Table 1.

Baseline characteristics comparison between two groups

Variable	Patients (n = 31)	Controls (n = 31)	Total (n = 62)	p-value¶
•Demographics
Male	71% (22)	52% (16)	61% (38)	0.192
Age, years	50 [17]	58 [14]	55 [18]	0.051
Overweight & obese	61% (19)	10% (3)	35% (22)	< 0.001*
Metabolic syndrome	29% (9)	10% (3)	19% (12)	0.106
• Anthropometrics
BMI, kg/m2	25 [6]	23 [4]	24 [5]	< 0.001*
WC, cm	96 [21]	81 [15]	89 [18]	< 0.001*
SCD, mm	16 [7]	11 [7]	15 [8]	< 0.001*
• Liver disease etiology
Viral (CHB, CHC)	35% (11)	-	-	-
MASLD	45% (14)	-	-	-
ALD	3% (1)	-	-	-
Coexistent CHB & ALD	10% (3)	-	-	-
Coexistent CHB & MASLD	6% (2)	-	-	-
• LSM in the supine position
LS, kPa	13.1 [7]	4.6 [1]	7.8 [9]	< 0.001*
IQR/median, %	24 [13]	26 [13]	25 [12]	0.368
Success rate§, %	100 [0]/100 ± 0	100 [0]/97 ± 6	100 [0]/99 ± 4	0.005*
• LSM in the seated position
LS, kPa	12.7 [7]	5.1 [2]	7.4 [8]	< 0.001*
IQR/median, %	24 [13]	30 [23]	25 [18]	0.208
Success rate§, %	100 [7]/96 ± 9	100 [0]/99 ± 2	100 [0]/98 ± 6	0.072
• LSM in the standing position
LS, kPa	13.0 [7]	6.2 [2]	7.9 [7]	< 0.001*
IQR/median, %	26 [20]	30 [19]	28 [18]	0.559
Success rate§, %	100 [0]/99 ± 3	100 [0]/99 ± 3	100 [0]/99 ± 3	0.687

All data are median [IQR] or % (n), unless otherwise indicated

ALD Alcoholic liver disease, BMI Body mass index, CHB Chronic hepatitis B, CHC Chronic hepatitis C, LS Liver stiffness, LSM Liver stiffness measurement, MASLD Metabolic dysfunction-associated steatotic liver disease, WC Waist circumference, SCD Skin-liver capsule distance

^¶Quantitative variables between groups were compared by Mann–Whitney U test; categorical variables were compared by Fisher’s exact test

^§Data are presented as median [IQR] / mean ± standard deviation

^* p < 0.05